Job details

AD/Director, Marketing Promotions

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.

At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.

As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.

To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.

Join us as we embark on an exciting journey in transforming the treatment landscape of acute myeloid leukemia (AML). We are searching for a dynamic and seasoned Associate Director/Director of Marketing to play a pivotal role in the development and implementation of comprehensive marketing strategies for our first commercial launch as an organization.

Reporting directly to the Senior Director of Brand Strategy and Marketing, you will be instrumental in crafting and executing integrated marketing plans to drive disease education, brand awareness and early adoption of our lead asset (ziftomenib). Working closely with cross-functional teams, your expertise in hematology/oncology, strategic thinking, and track record of successful marketing initiatives will be crucial in shaping, executing, and optimizing personalized omnichannel disease education and promotional campaigns targeted towards healthcare professionals (HCP), patients, caregivers and other relevant stakeholders.

Essential Job Functions

Campaign Development: Support the conceptualization and lead the implementation of integrated marketing campaigns, utilizing traditional and digital channels to effectively reach target audiences.
Strategic Planning: Collaborate on the development and execution of strategic marketing plans aligned with our overall business objectives, aligned to the brand positioning and strategy for our lead asset (ziftomenib).
Market Analysis: Utilize market research insights to uncover opportunities, identify trends, and assess competitive landscapes within the AML sector. Implement data-driven media and channel activation campaigns to optimize brand campaigns and performance.
Messaging: Contribute to the creation of compelling and differentiated messaging tailored for key stakeholders (HCP and Patients), ensuring consistent and high-impact communication across all channels.
Cross-functional Collaboration: Works closely with I&A, Medical Affairs, Sales, Legal, and Regulatory to ensure alignment and integration of marketing strategies and communications.
KOL Engagement: Foster meaningful relationships with National, Regional and Local opinion leaders in hematology/oncology to create peer-to-peer exchange to build brand influencers and advocates.
Budget Management: Contribute to the effective management of the marketing budget, optimizing resources to achieve maximum impact and return on investment.
Performance Measurement: Support establishing and monitoring of key performance indicators (KPIs) to evaluate the success of marketing initiatives and adjust strategies accordingly.

Job Requirements

Bachelor’s degree in relevant field, advanced degree preferred.
Minimum of 7 years of experience in marketing in the oncology or hematology space.
Proven track record of developing and implementing fully integrated marketing strategies. Must have the ability to effectively collaborate with, motivate and influence various levels/grades within the organization and outside of the organization.
Strong understanding of external stakeholder environment.
Knowledge of marketing, strategic and long-range planning, training, and market access
Excellent communication and interpersonal skills, with the ability to collaborate effectively with internal and external stakeholders.
Demonstrated ability to lead and inspire cross-functional teams.
Passion for improving the lives of patients and caregivers affected by oncology and hematology conditions. Ability to travel up to 15% of the time; domestic and limited international

The base range for an Associate Director is $180,000 - $188,000 and Director is $228,000 - $233,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.

Kura’s Values that are used for candidate selection and performance assessments:

We work as one for patients
We are goal-focused and deliver with excellence
We are science-driven courageous innovators
We strive to bring out the best in each other and ourselves

The Kura Package

Career advancement/ development opportunities
Competitive comp package
Bonus
401K + Employer contributions
Generous stock options
ESPP Plan
20 days of PTO to start
18 Holidays (Including Summer & Winter Break)
Generous Benefits Package with a variety of plans available with a substantial employer match
Paid Paternity/Maternity Leave
In-Office Catered lunches
Home Office Setup
Lifestyle Spending Stipend
Commuter Stipend (Boston Office)
Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!

Kura Oncology is a clinical-stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. The company’s diverse pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura Oncology’s approach to drug development is focused on rapidly translating novel science into life-saving medicines. Our goal is to help patients with cancer lead better, longer lives. Kura Oncology has offices in San Diego, California, and Boston, Massachusetts.

Kura’s pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806. Ziftomenib is a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction for the treatment of genetically defined AML patients with high unmet need. Ziftomenib is currently enrolling patients in a Phase 2 registration-directed trial (KOMET-001) in NPM1-mutant relapsed or refractory AML. Kura is preparing to initiate multiple Phase 1 trials to evaluate ziftomenib in combination with current standards of care in earlier lines of therapy and across multiple patient populations, including NPM1-mutant and KMT2A-rearranged AML. Tipifarnib, a potent and selective FTI, is currently in a Phase 1/2 trial (KURRENT-HN) in combination with alpelisib for patients with PIK3CA-dependent HNSCC. Kura intends to evaluate KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial (FIT-001) as a monotherapy and in combination with other targeted therapies in adult patients with advanced solid tumors. For additional information, please visit Kura’s website at www.kuraoncology.com.

Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.

Kura Oncology Glassdoor Company Review

3.3